| AASLD

Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

Read more about Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

Massih Ningarhari, Abbas Mourad, Claire Delacôte, Line‐Carolle Ntandja Wandji, Guillaume Lassailly, Alexandre Louvet, Sébastien Dharancy, Philippe Mathurin, Sylvie Deuffic‐Burban – 24 August 2022 – To validate cancer screening programs, experts recommend estimating effects on case fatality rates (CFRs) and cancer‐specific mortality. This study evaluates hepatocellular carcinoma (HCC) screening in patients with cirrhosis for those outcomes using a modeling approach.

Letter to the editor: Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality

Read more about Letter to the editor: Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality

Hong‐Xia Li, Zhi‐Qin Xie, Zhao‐Ming Yang, Cai‐Xi Tang – 24 August 2022

Reply

Read more about Reply

Laurens A. Kleef, Robert J. Knegt, Willem Pieter Brouwer – 24 August 2022

Letter to the editor: Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Read more about Letter to the editor: Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Wenhao Luo, Yawen Wang, Ye Li, Taiping Zhang – 24 August 2022

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy

Read more about Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy

Omar Alshuwaykh, Tami Daugherty, Amanda Cheung, Aparna Goel, Renumathy Dhanasekaran, T. Tara Ghaziani, Aijaz Ahmed, Deepti Dronamraju, Radhika Kumari, Allison Kwong, Mindie Nguyen, W. Ray Kim, Paul Yien Kwo – 24 August 2022 – Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular carcinoma (HCC). The aim of this study was to explore the incidence of HCC in a cohort of subjects with HBV and correlate with HBV treatment current guidance. We identified 2846 subjects with HBV over the study period.

Letter to the editor: Could COVID‐19 vaccination reduce postinfection mortality in most patients with cirrhosis?

Read more about Letter to the editor: Could COVID‐19 vaccination reduce postinfection mortality in most patients with cirrhosis?

Gin‐Ho Lo – 23 August 2022

Reply

Read more about Reply

Binu V. John, Bassam Dahman – 23 August 2022

Reply

Read more about Reply

Binu V. John, Bassam Dahman – 23 August 2022

Reply

Read more about Reply

Shikai Hu, Satdarshan P. Monga – 23 August 2022

β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma

Read more about β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma

Ruhi Gulati, Michael Johnston, Maria Rivas, Ashley Cast, Meenasri Kumbaji, Margaret A. Hanlon, Sanghoon Lee, Ping Zhou, Charissa Lake, Emily Schepers, Kyung‐Won Min, Je‐Hyun Yoon, Rebekah Karns, Lola M. Reid, Dolores Lopez‐Terrada, Lubov Timchenko, Sreeja Parameswaran, Matthew T. Weirauch, Sarangarajan Ranganathan, Alexander Bondoc, James Geller, Gregory Tiao, Soona Shin, Nikolai Timchenko – 23 August 2022 – Fibrolamellar hepatocellular carcinoma (FLC) is a disease that occurs in children and young adults.

Subscribe to